Candel Therapeutics, Inc.
CADL · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$55,177 | -$37,939 | -$18,794 | -$36,124 |
| Dep. & Amort. | $990 | $1,283 | $778 | $232 |
| Deferred Tax | $0 | $0 | $0 | $11,511 |
| Stock-Based Comp. | $5,312 | $3,091 | $2,307 | $2,963 |
| Change in WC | $346 | -$378 | $71 | -$876 |
| Other Non-Cash | $21,506 | -$301 | -$15,781 | $76 |
| Operating Cash Flow | -$27,023 | -$34,244 | -$31,419 | -$22,218 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$16 | -$457 | -$1,297 | -$1,835 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $177 | $0 | $0 |
| Investing Cash Flow | -$16 | -$280 | -$1,297 | -$1,835 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$9,167 | $0 | $19,910 | $0 |
| Stock Issued | $101,758 | $0 | $0 | $71,335 |
| Stock Repurch. | $0 | -$121 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1,689 | $0 | $64 | $465 |
| Financing Cash Flow | $94,280 | -$121 | $19,974 | $71,800 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $67,241 | -$34,645 | -$12,742 | $47,747 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $35,679 | $70,324 | $83,066 | $35,319 |
| End Cash | $102,920 | $35,679 | $70,324 | $83,066 |
| Free Cash Flow | -$27,039 | -$34,701 | -$32,716 | -$24,053 |